Plant Health Care PLC Result of Consultation (7947Z)

TIDMPHC

RNS Number : 7947Z

Plant Health Care PLC

18 May 2023

18 May 2023

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

Result of Consultation

On 2 May 2023, the Board of Plant Health Care announced its annual results for the year to 31 December 2022 ("FY22") and indicated that it proposed to evaluate a range of financing options for the Company and, as part of this process, that it would consult with shareholders as to whether AIM remained the right environment for the Company to achieve its ambitions.

The Company has made significant strategic and commercial progress over recent years and is on track to deliver long-term targeted revenue, cash breakeven and profitability, in line with its strategy. It was clear in the consultation process that investors are consistently supportive of the Company's track record of delivering growth over recent years. Moreover, the Board is encouraged that a number of shareholders were supportive of providing further capital to accelerate organic growth, if justified by returns over the current plan.

Whilst there are various perspectives within the shareholder base with regards to the listing on AIM and there is a broad acceptance that the Company is currently under-valued, there is clearly a prevailing view that the Company should remain listed. Having considered the feedback in full, the Board is pleased to confirm, therefore, that the Company remains committed to its listing on AIM, including for any potential funding needs.

The Board appreciates that investors have a favourable view of Plant Health Care, as the Company delivers its ambitious growth plans. The clarity provided through the consultation process will enable us to focus on driving the growth of the organic business, with support from shareholders. The Board expects that commercial delivery will be reflected in the share price performance of the Company in due course.

Chris Richards, Non-Executive Chairman of Plant Health Care, commented: "We are grateful to shareholders for taking part in the consultation. The Board is pleased with the strong support we received from investors for the Company's organic growth strategy, and their belief in the long-term prospects of the Company.

The Company will seek to continue delivering commercial progress through a diversified product offering and enhanced geographic reach. We have developed the exciting PREtec platform to deliver our future product pipeline and Harpin<ALPHA><BETA> continues to demonstrate strong growth. Delivering revenue growth of 40% in FY22 is testament to the quality of the management team and we remain on track to achieve our target of $30m revenue in 2025, achieving cash breakeven and profit along that track"

For further information, please contact:

 
 Plant Health Care plc 
 Jeffrey Tweedy, Chief Executive Officer   Tel: [phone] 
 Jeffrey Hovey, Chief Financial Officer 
 
  Cenkos Securities plc - Nomad & Broker     Tel: + (0) 131 220 9771 
  Neil McDonald / Pete Lynch 
 
 SEC Newgate (Financial Communications)    Tel:[phone] 
 Robin Tozer / George Esmond               Email: [e-mail] 
 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEAXSXFAXDEFA

(END) Dow Jones Newswires

May 18, 2023 02:00 ET (06:00 GMT)